A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALL

NCT06557161 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphoblastic Leukemia, Adult

Interventions

RADIATION: TBI
RADIATION: TMLI
DRUG: Cyclophosphamide

Sponsor

The First Affiliated Hospital of Zhengzhou University